Read this company snapshot
Daily valuation snapshot
Carlsmed, Inc. Common Stock: source evidence dated 2026-10-09.
- Daily close (USD)
- $14.42
- Market capitalization (USD)
- $393,705,554.06
- Price / earnings (TTM)
- Not reported
- Price / book
- 4.67
The source values and product destination above identify the example to inspect.
What business is this, and what does its dated valuation mean?
Check the market day first. P/E uses trailing earnings; book value and market capitalization answer different questions.
Daily valuation dataset and column definitionsOpen the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research CARL in the app
Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research CARL in the appKeep reporting dates and units beside the answer, and inspect its original citations.
Company overview
Carlsmed, Inc., a commercial-stage company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
Daily valuation snapshot
See the complete daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing CARL with another company.
| Daily close (USD) | $14.42 |
| Market capitalization (USD) | $393,705,554.06 |
| Price / earnings (TTM) | Not reported |
| Price / book | 4.67 |
No matching rows. Clear the filter to see all records.
Read CARL's valuation metrics
Company size
Carlsmed, Inc. Common Stock's recorded market capitalization is $393,705,554.06. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
CARL's recorded price-to-book ratio is 4.67. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research Carlsmed, Inc. Common Stock with Aurora
Use the snapshot above to ask a specific question about CARL. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow CARL's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.